跳至主要内容
临床试验/CTRI/2021/03/031616
CTRI/2021/03/031616
进行中(未招募)
未知

Evaluating the Use of Flavour-Stimulated Oral Fluids Collection for Severe Acute Respiratory Syndrome Coronavirus 2 Detection by Reverse Transcriptase Polymerase Chain Reaction and Enzyme Linked Immunosorbent Assay - a Concordance Study.

Datar Cancer Genetics0 个研究点目标入组 0 人待定

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
发起方
Datar Cancer Genetics
状态
进行中(未招募)
最后更新
3年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
3年前
研究类型
Observational

研究者

发起方
Datar Cancer Genetics

入排标准

入选标准

  • 1\. Known COVID\-19 positive by RTPCR (with active infection)
  • Known COVID\-19 negative by RTPCR (tested within 7 days)
  • 2\. Provision of Informed Consent
  • 3\. Willing to provide Nasopharyngeal Swab as well as Buccal Cavity Swab

排除标准

  • 1\. Pediatric patients.
  • 2\. Inability to provide Informed Consent.
  • 3\. Inability to provide Nasopharyngeal Swab and / or Buccal Cavity Swab.
  • 4\. Other conditions: allergic to latex.
  • 5\. Diagnosed with psychological conditions that restrict ability to comply with study procedures;
  • 6\. Prisoners and pregnant women
  • 7\. Subjects with pathologies relating to dental, oral and salivary conditions.
  • 8\. Subjects with allergies related to the components used in the kit.
  • 9\. Any other condition as judged by the PI which will restrict the ability to participate in the study and / or comply with study procedures.

结局指标

主要结局

未指定

相似试验